BIOFUSIONSPROTEINE ALS ANTI-MALARIA-IMPFSTOFFE
European patent · EP3487526 · In force
Register entry
- Publication number
- EP3487526
- Application number
- EP17746213
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 21, 2017
- Published
- May 29, 2019
- Granted
- Jul 6, 2022
- Protection ends at the latest
- Jul 20, 2037
- Next annual fee due
- Jul 31, 2027
- IPC classes
- A61K 39/015 (2006.01)A61K 39/385 (2006.01)A61K 39/00 (2006.01)
- Priority
- EP 16180544 21.07.2016
- PCT application
- PCT/SG2017/050369 21.07.2017
- PCT publication
- WO2018/017020 25.01.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 4, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 04.08.2026
- Aug 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2025 → 31.07.2026
Published in Swissreg on 01.08.2025
- Jan 31, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2024 → 31.07.2025
Published in Swissreg on 31.01.2025
- Aug 1, 2023
Change
Published in Swissreg on 01.08.2023
- May 17, 2023
Change
Published in Swissreg on 17.05.2023
- Oct 25, 2022
Change
Published in Swissreg on 25.10.2022
- Jul 6, 2022
Granted
Published in Swissreg on 06.07.2022
Parties
Inventor
DRUILHE, Pierre
75015 Paris, FR
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.